Oregon Health & Science University Knight Cancer Institute | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Oregon Health & Science University Knight Cancer Institute

Oregon Health & Science University Knight Cancer Institute

3181 S.W. Sam Jackson Park Road
Portland, Oregon, United States
Email   Phone   Web  

The Oregon Health & Science University (OHSU) Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment. Driven by its mission to end cancer, the institute is building upon its expertise in targeted treatments to advance the early detection of cancer when the disease is most treatable.

OHSU Knight Cancer Institute Director Brian Druker, M.D., revolutionized the treatment of cancer through research that resulted in the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed. Marketed under the name Gleevec®, his discovery turned a once-fatal cancer, chronic myeloid leukemia, into a manageable condition.

At the OHSU Knight Cancer Institute, a team of doctors, nurses and therapists is dedicated to diagnosing, treating and managing amyloidosis. Their amyloidosis doctors have extensive knowledge about amyloidosis diagnosis and treatment and meet weekly to discuss all patients, benefiting them of the entire team’s knowledge and expertise.

Healthcare professionals at Oregon Health & Science University specialise in the following areas:

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close